Digg
Del.icio.us
Newsvine 
Facebook
Stumbleupon
Drug discovery technology and information company Cyprotex current trading revenues are expected to be in line with 2008.
It said conditions remain challenging and in Q4, normally the strongest quarter, it had experienced lower than expected demand in general and from its largest customer.
But it said new business enquiries during the quarter had been more buoyant and the company remains cash generative with cash in hand at 31 October of 1.98m against 1.72m at the end of June.
Story provided by Business Financial Newswire
Shares in British banks rose on the FTSE 100 a day after the Chief Executive of Citigroup predicted strong growth for the American bank and said ...
Liberty, owner of the iconic London department store, said it was in the early s...
© 2010 The IBTimes Company Ltd. All Rights Reserved.
Partners 
EMAIL
PRINT
RSS
SHARE
